miR-30e* is an independent subtype-specific prognostic marker in breast cancer
about
Decoding the usefulness of non-coding RNAs as breast cancer markersmiR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular CarcinomamiR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer.Noncoding RNAs in breast cancer.Positive expression of miR-361-5p indicates better prognosis for breast cancer patients.SOX2 regulates multiple malignant processes of breast cancer development through the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis.Overexpression of Transforming Acidic Coiled Coil‑Containing Protein 3 Reflects Malignant Characteristics and Poor Prognosis of Glioma.MicroRNA-7 suppresses the homing and migration potential of human endothelial cells to highly metastatic human breast cancer cells.The miR-30 family: Versatile players in breast cancer.MicroRNA-30e Functions as a Tumor Suppressor in Cervical Carcinoma Cells through Targeting GALNT7Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.MicroRNA-30e-5p promotes cell growth by targeting PTPN13 and indicates poor survival and recurrence in lung adenocarcinoma.Association of miR-548c-5p, miR-7-5p, miR-210-3p, miR-128-3p with recurrence in systemically untreated breast cancer.Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkersGenome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
P2860
Q28069370-7521DDA4-68B2-451A-BE4B-55B4E6CC4408Q36191985-42732C31-F9B0-4893-A398-4F461A547ABAQ36509109-14DAF180-615B-456B-AC65-27E08EA774AEQ36797492-31D1DC34-7473-448E-A6E7-FF4DE6A93872Q36935047-93841692-F38B-4D72-B884-AFDB9EF7A3EFQ37121435-1B40EA5B-9F91-446F-A98F-6DCB9F0921B7Q37697914-392B3F3F-D3C4-47B6-A76F-A220B3687761Q37728965-4F94C82E-47E0-4355-A569-0A9152B673E1Q38701611-180E041A-D9B5-4EF3-819F-AE980D682666Q39202832-346AC48C-4C23-4EDE-8CAE-6F568206225EQ42368450-F3D95919-7E93-4B61-8F3A-E0D721628984Q42500574-5501B08E-1D85-479D-BB5A-FF45360D6F72Q42931487-EC9F9EFD-4ED4-4470-B7F9-9E4CFC33648CQ55011586-2617E1E1-624E-465C-8550-C68A0D2828DFQ57816466-103C9C9E-4D09-456E-BDF8-74A2391FCF73Q58790645-64E67653-53AC-45D8-ABDE-6C4EBF0568C6
P2860
miR-30e* is an independent subtype-specific prognostic marker in breast cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
miR-30e* is an independent subtype-specific prognostic marker in breast cancer
@ast
miR-30e* is an independent subtype-specific prognostic marker in breast cancer
@en
type
label
miR-30e* is an independent subtype-specific prognostic marker in breast cancer
@ast
miR-30e* is an independent subtype-specific prognostic marker in breast cancer
@en
prefLabel
miR-30e* is an independent subtype-specific prognostic marker in breast cancer
@ast
miR-30e* is an independent subtype-specific prognostic marker in breast cancer
@en
P2860
P50
P356
P1476
miR-30e* is an independent subtype-specific prognostic marker in breast cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2015.206
P407
P50
P577
2015-06-09T00:00:00Z